id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-4853-0005,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant,Notice,General Notice,2023-03-07T05:00:00Z,2023,3,2023-03-07T05:00:00Z,,2023-03-07T14:10:47Z,2023-04583,0,0,090000648576d48a